Verrica Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Verrica Pharmaceuticals

14/08/2024 14:51

* Verrica Pharmaceuticals Inc  VRCA.OQ  reported a quarterly
adjusted loss of 37 cents​​ per share for the quarter ended in
June, lower than the same quarter last year, when the company
reported EPS of -24 cents.  The mean expectation of six analysts
for the quarter was for a loss of 42 cents per share. Wall
Street expected results to range from -47 cents to -36 cents per
share.
    * Revenue rose 2,744.5% to $5.18 million from a year ago;
analysts
expected $4.37 million. 
    * Verrica Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 37 cents​.
    * The company reported a quarterly loss of $17.19 million.
    * Verrica Pharmaceuticals Inc shares had fallen by 27.7%
this
quarter and lost 28.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Verrica
Pharmaceuticals Inc is $14.50 
This summary was machine generated from LSEG data August 14 at
01:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.42          -0.37          Beat
 Mar. 31 2024      -0.40          -0.44          Missed
 Dec. 31 2023      -0.53          -0.53          Met
 Sep. 30 2023      -0.36          -0.54          Missed